Cardiology Flashcards

1
Q

Clinical signs of Aortic Stenosis

A
  1. Slow rising, low volume pulse
  2. Narrow pulse pressure
  3. Apex beat is sustained in stenosis (HP: heaving pressure‐loaded)
  4. Thrill in aortic area (right sternal edge, second intercostal space)
  5. Auscultation:
    A crescendo-decrescendo, ejection systolic murmur (ESM) loudest in the aortic area during expiration and radiating to the carotids.
    Severity:
    soft and delayed A2 due to immobile leaflets and prolonged LV emptying, delayed (not loud) ESM, fourth heart sound S4.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Auscultation in Aortic stenosis

A

A crescendo-decrescendo, ejection systolic murmur (ESM) loudest in the aortic area during expiration and radiating to the carotids.

Severity:
Soft and delayed A2 due to immobile leaflets and prolonged LV emptying, delayed (not loud) ESM, fourth heart sound S4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Evidence of complications in Aortic stenosis

A
  1. Endocarditis:
    Splinters, Osler’s nodes (finger pulp), Janeway lesions (palms), Roth spots (retina), temperature, splenomegaly and haematuria
  2. Left ventricular dysfunction:
    Dyspnoea, displaced apex and bibasal crackles
  3. Conduction problems:
    –> acute, endocarditis;
    –> chronic, calcified aortic valve node
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Differential diagnosis of Aortic stenosis

A
  1. HOCM
  2. VSD
  3. Aortic sclerosis: normal pulse character and no radiation of murmur
  4. Aortic flow: high output clinical states e.g. pregnancy or anaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Causes of Aortic stenosis

A
  1. Congenital: bicuspid aortic valve
  2. Acquired:
    - -> Age (senile degeneration and calcification);
    - -> Streptococcal (rheumatic)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Associations of Aortic stenosis

A
  1. Coarctation
  2. Bicuspid aortic valve
  3. Angiodysplasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Severity of Aortic stenosis

A

• Signs
* Auscultation features:
Soft and delayed A2 due to immobile leaflets and prolonged LV emptying, delayed (not loud) ESM, fourth heart sound S4
* Mortality risk:
- Angina 50% mortality at 5 years
- Syncope 50% mortality at 3 years
- Breathlessness 50% mortality at 2 years
* Biventricular failure (right ventricular failure is preterminal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Investigations in Aortic stenosis

A
  1. ECG: LVH on voltage criteria, conduction defect (prolonged PR interval)
  2. CXR: often normal; calcified valve
  3. Echo: mean gradient: >40 mm Hg aortic (valve area <1.0 cm2) if severe
  4. Catheter: invasive transvalvular gradient and coronary angiography (coronary artery disease often coexists with aortic stenosis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Management of Aortic Stenosis

A
  1. Asymptomatic
    ⚬⚬ None specific, good dental health
    ⚬⚬ Regular review: symptoms and echo to assess gradient and LV function
  2. Symptomatic
    A- ⚬⚬ Surgical
    1- ⚬⚬ Aortic valve replacement +/− CABG
    2- ⚬⚬ Operative mortality 3–5% depending on the patient’s EuroScore (www.euroscore.org/calc.html)

B- ⚬⚬ Percutaneous
1- ⚬⚬ Balloon aortic valvuloplasty (BAV)
2- ⚬⚬ Transcutaneous aortic valve implantation (TAVI)
a- ⚬⚬ Transfemoral (or transapical and transaortic)
b- ⚬⚬ Maybe recommended
–> if high surgical risk (logEuroscore >20%) or
–> inoperable cases (number needed to treat to prevent death at 1 year = 5)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Duke’s criteria for infective endocarditis

A

Major:
• Typical organism in two blood cultures
• Echo: abscess, large vegetation, dehiscence*
Minor:
• Pyrexia >38°C
• Echo suggestive
• Predisposed, e.g. prosthetic valve
• Vascular phenomenon, including major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctival hemorrhage, or Janeway lesions
• Immunologic/Vasculitic phenomenon such as glomerulonephritis, Osler nodes, Roth spots, and rheumatoid factor, (ESR↑, CRP↑)
• Atypical organism on blood culture
Diagnose if the patient has 2 major, 1 major and 2 minor, or 5 minor criteria.
(* plus heart failure/refractory to antibiotics/heart block are indicators for urgent surgery).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Indications for antibiotic prophylaxis for Infective Endocarditis

A

Antibiotic prophylaxis is now limited to those with
1- Prosthetic valves,
2- Previous endocarditis,
3- Cardiac transplants with valvulopathy and
4- Certain types of congenital heart disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clinical signs of Aortic Incompetence

A
  1. Collapsing pulse (water-hammer pulse) reflecting a wide pulse pressure, e.g. 180/45
  2. Apex beat is hyperkinetic and displaced laterally (TV: thrusting volume‐loaded)
  3. Thrill in the aortic area
  4. Auscultation:
    - Early diastolic murmur (EDM) loudest at the lower left sternal edge with the patient sat forward in expiration.
    - There may be an aortic flow murmur and a mid-diastolic murmur (MDM) (Austin–Flint) due to regurgitant flow impeding mitral opening.
    - In severe AR there may be ‘free flow’ regurgitation and
    the EDM may be silent.
  5. Signs of severity:
    collapsing pulse, third heart sound (S3) and pulmonary oedema
  6. Eponymous signs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

• Auscultation in Aortic Incompetence

A
  1. Early diastolic murmur (EDM) loudest at the lower left sternal edge with the patient sat forward in expiration.
  2. There may be an aortic flow murmur and a mid-diastolic murmur (MDM) (Austin–Flint) due to regurgitant flow impeding mitral opening.
  3. In severe AR there may be ‘free flow’ regurgitation and the EDM may be silent.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Eponymous signs in Aortic Incompetence

A
  1. Corrigan’s: visible vigorous neck pulsation
  2. Quincke’s: nail bed capillary pulsation
  3. De Musset’s: head nodding
  4. Duroziez’s: diastolic murmur proximal to femoral artery compression
  5. Traube’s: ‘pistol shot’ sound over the femoral arteries
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Congenital Causes of Aortic Incompetence

A
  1. Bicuspid aortic valve;

2. Perimembranous VSD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Acquired Causes of Aortic Incompetence

A

** Valve leaflet:
(Acute) - Endocarditis,
(Chronic) 1- Rheumatic fever or 2- Drugs: pergolide, slimming agents

**Aortic root
(Acute): 1- Dissection (type A) 2- Trauma
(Chronic): 1- Dilatation: Marfan’s and hypertension, 2- Aortitis: syphilis, ankylosing spondylitis and vasculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Other causes of a collapsing pulse

A
  1. Pregnancy
  2. Patent ductus arteriosus
  3. Paget’s disease
  4. Anaemia
  5. Thyrotoxicosis
  6. AR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Investigation in Aortic Incompetence

A
  1. ECG: lateral T‐wave inversion
  2. CXR: cardiomegaly, widened mediastinum and pulmonary oedema
  3. TTE/TOE:
    - Severity: LVEF and dimensions, root size, jet width
    - Cause: intimal dissection flap or vegetation
  4. Cardiac catheterization: grade severity aortogram and check coronary patency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Medical Management of Aortic Incompetence

A
  • ACE inhibitors and ARBs (reducing afterload)

* Regular review: symptoms and echo: LVEF, LV size and degree of AR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Indications for Surgery in Aortic Incompetence

A

Acute:
1. Dissection
2. Aortic root abscess/endocarditis (homograft preferably)
Chronic:
Replace the aortic valve when:
• Symptomatic: dyspnoea and reduced exercise tolerance (NYHA > II) AND/OR
• The following criteria are met:
1. wide pulse pressure >100 mm Hg
2. ECG changes (on Exercise Tolerance Test)
3. Echo: LV enlargement >5.5 cm systolic diameter or EF <50%
Ideally replace the valve prior to significant LV dilatation and dysfunction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Prognosis of Aortic Incompetence

A

Asymptomatic with EF > 50% – 1% mortality at 5 years.

Symptomatic and all three criteria present − 65% mortality at 3 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Clinical signs of Mitral stenosis

A
  1. Malar flush
  2. Irregular pulse if AF is present
  3. Tapping apex (palpable first heart sound)
  4. Left parasternal heave if pulmonary hypertension is present or enlarged left atrium
  5. Auscultation
    - Loud 1rst heart sound.
    - Opening snap (OS) of mobile mitral leaflets opening
    followed by a mid-diastolic murmur (MDM), which is best
    heard at the apex, in the left lateral position in expiration with the bell.
    - Presystolic accentuation of the MDM occurs if the patient is in sinus rhythm.
    - If the mitral stenosis is severe then the OS occurs nearer A2 and the MDM is longer.
  6. Haemodynamic significance
    - Pulmonary hypertension: functional tricuspid regurgitation, right ventricular heave, loud P2.
    - LVF: pulmonary oedema, RVF: sacral and pedal oedema.
  7. Endocarditis
  8. Embolic complications: stroke risk is high if mitral stenosis + AF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Causes of Mitral stenosis

A
Congenital: (rare)
Acquired
1. Rheumatic (commonest)
2. Senile degeneration
3. Large mitral leaflet vegetation from endocarditis (mitral ‘plop’ and late diastolic murmur)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Differential diagnosis of Mitral stenosis

A
  1. Left atrial myxoma

2. Austin–Flint murmur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Investigation of Mitral stenosis

A
  1. ECG: p‐mitrale (broad, bifid) and atrial fibrillation
  2. CXR: enlarged left atrium (splayed of carina), calcified valve, pulmonary oedema
  3. TTE/TOE: valve area (<1.0 cm2 is severe), cusp mobility, calcification and left atrialthrombus, right ventricular failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Management of Mitral stenosis

A
  1. Medical: + AF: rate control and oral anticoagulants, diuretics
  2. Mitral valvuloplasty: if pliable, non‐calcified with minimal regurgitation and no left atrial thrombus
  3. Surgery:
    - —–> closed mitral valvotomy (without opening the heart) or
    - —–> open valvotomy (requiring cardiopulmonary bypass) or
    - —–> valve replacement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Prognosis of Mitral stenosis

A

Latent asymptomatic phase 15–20 years;

NYHA > II – 50% mortality at 5 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Pathophysiology of Rheumatic fever

A

• Immunological cross‐reactivity between Group A β‐haemolytic streptococcal infection,
e.g. Streptococcus pyogenes and valve tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Duckett–Jones diagnostic criteria of Rheumatic fever

A

Proven β‐haemolytic streptococcal infection diagnosed by throat swab, rapid antigen detection test (RADT), anti streptolysin O titre (ASOT) or clinical scarlet fever plus 2 major or 1 major and 2 minor:
** Major: ======================** Minor:
——> Chorea, ================——> Raised ESR,
——> Erythema marginatum, ====——> Raised WCC,
——> Subcutaneous nodules, ===——> Previous RhF,
——> Polyarthritis, =============——> Arthralgia,
——> Carditis =================——> Pyrexia,
=============================——> Prolonged PR interval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Treatment of Rheumatic fever

A

Rest, high‐dose aspirin and penicillin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Prophylaxis of Rheumatic fever

A

⚬⚬ Primary prevention: penicillin V (or clindamycin) for 10 days
⚬⚬ Secondary prevention: penicillin V for about 5–10 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Clinical signs of Mitral incompetence

A
  1. Scars: lateral thoracotomy (valvotomy)
  2. Pulse: AF, small volume
  3. Apex: displaced and volume loaded
  4. Palpation: thrill at apex
  5. Auscultation:
    - Pan-systolic murmur (PSM) loudest at the apex radiating to the axilla. Loudest in expiration.
    - Wide splitting of A2 P2 due to the earlier closure of A2 because the LV empties sooner.
    - S3 indicates rapid ventricular filling from LA, and excludes significant mitral stenosis.
  6. Pulmonary oedema
  7. Evidence of the Cause: signs of endocarditis
  8. Severity: left ventricular failure and atrial fibrillation (late). Not murmur intensity
  9. Other murmurs, e.g. ASD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Congenital Causes of Mitral incompetence

A

There is an association between cleft mitral valve and primum ASD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Acquired Causes of Mitral incompetence

A
  • Valve leaflets
    • Acute
  • > Bacterial endocarditis
    • Chronic
  • > Myomatous degeneration (prolapse)
  • > Rheumatic
  • > Connective tissue diseases
  • > Fibrosis (fenfluramine/pergolide)
  • Valve annulus
    • Chronic
  • > Dilated left ventricle (functional MR)
  • > Calcification
  • Chordae/papillae
    • Acute
  • > Rupture
    • Chronic:
  • > Infiltration, e.g. amyloid
  • > Fibrosis (post‐MI/trauma)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Investigation of Mitral incompetence

A
  1. ECG: p‐mitrale, atrial fibrillation and previous infarction (Q waves)
  2. CXR: cardiomegaly, enlargement of the left atrium and pulmonary oedema
  3. TTE/TOE:
    - Severity: size/density of MR jet, LV dilatation and reduced EF
    - Cause: prolapse, vegetations, ruptured papillae, fibrotic restriction and infarction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Management of Mitral incompetence

A

1- Medical
⚬⚬ Anticoagulation for atrial fibrillation or embolic complications
⚬⚬ Diuretic, β‐blocker and ACE inhibitors
2- Percutaneous: mitral clip device for palliation in inoperative cases of mitral valve prolapse
3- Surgical
⚬⚬ Valve repair (preferable) with annuloplasty ring or replacement
⚬⚬ Aim to operate when symptomatic, prior to severe LV dilatation and dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Prognosis of Mitral incompetence

A
  • Often asymptomatic for >10 years

* Symptomatic – 25% mortality at 5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Mitral valve prolapse

A

• Common (5%), especially young tall women
• Associated with connective tissue disease, e.g. Marfan’s syndrome and HOCM
• Often asymptomatic, but may present with chest pain, syncope and palpitations
• Small risk of emboli and endocarditis
• Auscultation
-> Mid-systolic ejection click (EC).
-> Pan-systolic murmur that gets louder up to A2.
-> Murmur is accentuated by standing from a squatting position or during the straining phase of the Valsalva manoeuvre, which reduces the ‚flow of blood through the heart.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Clinical signs of Tricuspid incompetence

A
  1. Raised JVP with giant CV waves
  2. Thrill left sternal edge
  3. Auscultation:
    - > Pan-systolic murmur (PSM) loudest at the tricuspid area (lower left sternal edge) in inspiration.
    - > Reverse split second heart sound due to rapid RV emptying.
    - > Right ventricular rapid filling gives an S3
  4. Pulsatile liver, ascites and peripheral oedema
  5. Endocarditis from IV drug abuse: needle marks
  6. Pulmonary hypertension: RV heave and loud P2
  7. Other valve lesions: rheumatic mitral stenosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Causes of Tricuspid incompetence

A

• Congenital: Ebstein’s anomaly (atrialization of the right ventricle and TR)
• Acquired:
-> Acute: infective endocarditis (IV drug user)
-> Chronic: functional (commonest), rheumatic and carcinoid syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Investigation of Tricuspid incompetence

A
  1. ECG: p‐pulmonale (large, peaked) and RVH
  2. CXR: double right heart border (enlarged right atrium)
  3. TTE: TR jet, RV dilatation
42
Q

Management of Tricuspid incompetence

A
  • Medical: diuretics, β‐blockers, ACE inhibitors and support stockings for oedema
  • Surgical: valve repair/annuloplasty if medical treatment fails
43
Q

Clinical signs Pulmonary stenosis

A
  1. Raised JVP with giant a waves
  2. Left parasternal heave
  3. Thrill in the pulmonary area
  4. Auscultation:
    - > Ejection systolic murmur (ESM) heard loudest in the pulmonary area in inspiration.
    - > Widely split second heart sounds, due to a delay in RV emptying.
    - > Severe: inaudible P2, longer murmur duration obscuring A2.
  5. Right ventricular failure: ascites and peripheral oedema
  6. Tetralogy of Fallot: PS, VSD, overriding aorta and RVH (sternotomy scar)
  7. Noonan’s syndrome: phenotypically like Turner’s syndrome but male sex
  8. Other murmurs: functional TR and VSD
44
Q

Investigation of Pulmonary stenosis

A
  1. ECG: p‐pulmonale, RVH and RBBB
  2. CXR: oligaemic lung fields and large right atrium
  3. TTE: severity (pressure gradient), RV function and associated cardiac lesions
45
Q

Management of Pulmonary stenosis

A
  1. Pulmonary valvotomy – if gradient >70 mm Hg or there is RV failure
  2. Percutaneous pulmonary valve implantation (PPVI)
  3. Surgical repair/replacement
46
Q

Carcinoid syndrome

A
  1. Gut primary with liver metastasis secreting 5‐HT into the blood stream
  2. Toilet‐symptoms: diarrhoea, wheeze and flushing!
  3. Secreted mediators cause right‐sided heart valve fibrosis resulting in tricuspid regurgitation and/or pulmonary stenosis
  4. Rarely a bronchogenic primary tumour or a right‐to‐left shunt can release 5‐HT into the systemic circulation and cause left‐sided valve scarring
  5. Treatment: octreotide or surgical resection
47
Q

Clinical signs in prosthetic valves

A

• Audible prosthetic clicks (metal) on approach and scars on inspection
1- Midline sternotomy (CABG, AVR, MVR)
2- Lateral thoracotomy (MVR, mitral valvotomy, coarctation repair, BT shunt)
3- Subclavicular (Pacemaker, AICD)
4- Anticubital fossa (angiography)

–> Also look in the wrist and groins for angiography scars/bruising and legs for saphenous vein harvest used in bypass grafts.
• Anticoagulation: bruises (metal valve) and anaemia

48
Q

Aortic valve replacement Auscultation

A

-> A metal prosthetic closing click (CC) is heard instead of A2.
-> There may be an opening click (OC) and ejection systolic flow murmur.
-> A bioprosthesetic valve often has normal heart sounds.
-> Abnormal findings:
==> AR
==> Decreased intensity of the closing click (clot or vegetation)

49
Q

Mitral valve replacement Auscultation

A

-> A metal prosthetic closing click is heard instead of S1.
-> An opening click may be heard in early diastole followed by a low-frequency diastolic rumble.
-> Abnormal findings:
==> MR
==> Decreased intensity of the closing click.

50
Q

Choice of valve replacement (Metal Vs Procaine)

A
Metal:
--> Durable
--> needs warfarin
--> Indicated for: Young Pt/on warfarin, e.g. for AF 
Procaine:
--> Less durable
--> No warfarin 
--> Indicated for: Elderly/at risk of haemorrhage
51
Q

• Operative mortality in valve replacment

A

3–5%

52
Q

Late complications of Prosthetic Valves

A

1• Thromboembolus: 1–2% per annum despite warfarin
2• Bleeding: fatal 0.6%, major 3%, minor 7% per annum on warfarin
3• Bioprosthetic dysfunction and LVF : usually within 10 years, can be treated percutaneously (valve‐in‐valve)
4• Haemolysis: mechanical red blood cell destruction against the metal valve
5• Infective endocarditis:
⚬⚬> Early infective endocarditis (<2/12 post‐op) can be due to Staphylococcus epidermidis from skin
⚬⚬> Late infective endocarditis is often due to Strep. viridans by haematogenous spread
⚬⚬> A second valve replacement is usually required to treat this complication
⚬⚬> Mortality of prosthetic valve endocarditis approaches 60%
6• Atrial fibrillation: particularly if MVR

53
Q

Clinical signs of Implantable Device

A
  1. Incisional scar in the infraclavicular position (may be abdominal)
  2. Palpation demonstrates a pacemaker
  3. Signs of heart failure: raised JVP, bibasal crackles and pedal oedema
  4. Medic alert bracelet
  5. Local infection: red/hot/tender/fluctuant/erosion
54
Q

Implantable cardioverter defibrillators (ICDs) are recommended as options for:

A

1- treating people with previous serious ventricular arrhythmia, that is without a treatable cause in people who have:

  • -> Survived a cardiac arrest caused by either VT or VF or
  • -> Spontaneous sustained VT causing syncope or significant haemodynamic compromise or
  • -> Sustained VT without syncope or cardiac arrest, and also have an associated reduction in LVEF ≤ 35% but their symptoms are no worse than NYHA class III.

2- treating people who have:

  • -> A familial cardiac condition with a high risk of sudden death, such as LQTS, HOCM, Brugada syndrome or arrhythmogenic right ventricular dysplasia or
  • -> Undergone surgical repair of congenital heart disease.
55
Q

Implantable cardioverter defibrillators (ICDs)
Cardiac resynchronisation therapy (CRT) with defibrillator (CRT‑D) or
CRT with pacing (CRT‑P)
are recommended as treatment options for:

A
Patient with heart failure who have left ventricular dysfunction with a LVEF ≤ 35% according to QRS duration, NYHA class and presence of LBBB
1- QRS interval <120 milliseconds
==> NYHA class I, II, III : ICD if there is a high risk of sudden cardiac death
==> NYHA class IV: ICD and CRT not clinically indicated
2- QRS interval 120–149 milliseconds without LBBB
==> NYHA class I, II, III : ICD
==> NYHA class IV: CRT-P
3- QRS interval 120–149 milliseconds with LBBB:
==> NYHA class I: ICD
==> NYHA class II: CRT-D
==> NYHA class III: CRT-P or CRT-D
==> NYHA class V: CRT-P
4- QRS interval ≥150 milliseconds with or without LBBB:
==> NYHA class I: CRT-D
==> NYHA class II: CRT-D
==> NYHA class III: CRT-P or CRT-D
==> NYHA class V: CRT-P

NB: Cardiac resynchronization therapy (CRT ) = biventricular pacemakers (BiV)

56
Q

Implantable cardiac defibrillators (ICD)

A

‘Shock box’ also delivers anti‐tachycardia pacing (ATP) – improves mortality

57
Q

Indications of ICD as a Primary prevention

A
  1. MI > 4 weeks ago (NYHA no worse than class III)
    ⚬⚬ LVEF < 35% and non‐sustained VT and positive EP study or
    ⚬⚬ LVEF < 30% and QRSd ≥ 120 milliseconds
    • Familial condition with high‐risk SCD
    ⚬⚬ LQTS, ARVD, Brugada, HCM, complex congenital heart disease
58
Q

Secondary prevention (without other treatable cause)

A
  • cardiac arrest due to VT or VF or
  • haemodynamically compromising VT or
  • VT with LVEF < 35% (not NYHA IV)
59
Q

Cardiac resynchronization therapy (CRT ) – biventricular pacemakers (BiV)

A

Extra LV pacemaker lead via the coronary sinus – improves mortality/symptoms
May be considered if:
• LVEF < 35%
• NYHA II–IV on optimal medical therapy
• Sinus rhythm and QRSd > 150 milliseconds (if LBBB morphology may be >120 milliseconds)

60
Q

Constrictive pericarditis presentation

A

This man has had previous mantle radiotherapy for lymphoma and has a chronic history of leg oedema, bloating and weight gain.

61
Q

Clinical signs of Constrictive pericarditis

A

Predominantly right‐side heart failure
A. Raised JVP
⚬⚬ Dominant, brief y‐descent due to rapid early ventricular filling and rise in diastolic pressure
⚬⚬ Kussmaul’s sign: paradoxical increase in JVP on inspiration (may need to sit the patient at 90° rather than 45° to observe the JVP meniscus)
B. Pulsus paradoxus:
⚬⚬ >10 mm Hg drop in systolic pressure in inspiration (not a true paradox as it normally decreases by 2–3 mm Hg!)
C. Auscultation:
⚬⚬ Pericardial knock – it’s not a knock but a high‐pitched snap (audible, early S3 due to rapid ventricular filling into a stiff pericardial sac)
D. Ascites, hepatomegaly (congestion) and bilateral peripheral oedema

62
Q

Causes of Constrictive pericarditis

A

⚬⚬ TB: cervical lymphadenopathy
⚬⚬ Trauma (or surgery): sternotomy scar, post‐MI
⚬⚬ Tumour, Therapy (radio): radiotherapy tattoos, thoracotomy scar
⚬⚬ Connective Tissue disease: rheumatoid hands, SLE signs

63
Q

Investigation for Constrictive pericarditis

A
  1. CXR: pericardial calcification, old TB, sternotomy wires
  2. Echo: high acoustic signal from pericardium, septal bounce, reduced mitral flow velocity during inspiration
  3. Catheter laboratory:
    ⚬⚬ Dip and plateau of the diastolic wave form: square‐root sign
    ⚬⚬ Equalization of LV and RV diastolic pressures
  4. CT: thickened pericardium
64
Q

Pathophysiology of Constrictive pericarditis

A

⚬⚬ Thickened, fibrous capsule reduces ventricular filling and ‘insulates’ the heart from intrathoracic pressure changes during respiration leading to ventricular interdependence – filling of one ventricle reduces the size and filling of the other.

65
Q

• Treatment of Constrictive pericarditis

A

⚬⚬ Medical: diuretics and fluid restriction

⚬⚬ Surgical: pericardial stripping

66
Q

Differentiating pericardial constriction from restrictive cardiomyopathy

A

It is difficult to differentiate pericardial constriction from restrictive cardiomyopathy but observing ventricular interdependence (fluctuating LV/RV pressure or MV/TV flow velocities during respiration) is highly diagnostic for constriction!

67
Q

Atrial septal defect presentation

A

This young woman complains of cough and occasional palpitations. Examine her cardiovascular system.

68
Q

Clinical signs of Atrial septal defect

A

• Raised JVP
• Pulmonary area thrill
• Auscultation
–> Fixed split-second heart sounds that do not change with respiration.
–> Pulmonary ejection systolic and mid-diastolic flow murmurs with large left-to-right shunts.
–> There is no mumur from the ASD itself.

** Consider:
• Pulmonary hypertension: RV heave and loud P2, + cyanosis and clubbing (Eisenmenger’s: right‐to‐left shunt)
• Congestive cardiac failure

69
Q

Types of Atrial septal defect

A
  • Primum associated with AVSD and cleft mitral valve) seen in Down’s syndrome
  • Secundum (commonest)
70
Q

Complications of Atrial septal defect

A
  • Paradoxical embolus
  • Atrial arrhythmias
  • RV dilatation
71
Q

Investigation of Atrial septal defect

A
  • ECG: RBBB + LAD (primum) or + RAD (secundum); atrial fibrillation
  • CXR: small aortic knuckle, pulmonary plethora and double‐heart‐border (enlarged RA)
  • TTE/TOE: site, size and shunt calculation; amenability to closure
  • Right heart catheter shunt calculation (not always necessary)
72
Q

Indications for closure of Atrial septal defect

A
  • Symptomatic: paradoxical systemic embolism, breathlessness

* Significant shunt: Qp:Qs>1.5:1, RV dilatation

73
Q

Contraindication for closure of Atrial septal defect:

A

• Severe pulmonary hypertension and Eisenmenger’s syndrome

74
Q

Closure of Atrial septal defect:

A

• Percutaneous closure device
⚬⚬> Secundum ASD only, no left atrial appendage thrombus or anomalous pulmonary venous drainage, adequate rim to anchor device
• Surgical patch repair

75
Q

Ventricular septal defect

A

This patient has developed sudden shortness of breath. Examine his heart.

76
Q

Clinical signs of Ventricular septal defect

A

• Thrill at the lower left sternal edge
• Auscultation:
–> Systolic murmur well localized at the left sternal edge with no radiation.
–> No Audible A2.
–> Loudness does not correlate with size (Maladie de Roger: loud murmur due to high-ow velocity through a
small VSD).
–> If Eisenmenger’s develops the murmur often disappears as the gradient diminishes.

77
Q

Extra points to Consider in Ventricular septal defect

A
  • Other associated lesions: AR, PDA (10%), Fallot’s tetralogy and coarctation
  • Pulmonary hypertension: loud P2 and RV heave + cyanosis and clubbing (Eisenmenger’s)
  • Endocarditis
78
Q

Causes of VSD

A
  • Congenital

* Acquired (traumatic, post‐operative or post‐MI)

79
Q

Investigation for VSD

A
  • ECG: conduction defect: BBB
  • CXR: pulmonary plethora
  • TTE/TOE: site, size, shunt calculation and associated lesions
  • Cardiac catheterization: consideration of closure
80
Q

Management of VSD

A

Surgical (pericardial patch) or percutaneous (Amplatzer® device) closure of haemodynamically significant defects.

81
Q

Associations with VSD

A
  1. Fallot’s tetralogy
  2. Coarctation
  3. Patent ductus arteriosus (PDA)
82
Q

Fallot’s tetralogy

A
  • Right ventricular hypertrophy
  • Overriding aorta
  • VSD
  • Pulmonary stenosis
83
Q

–> Blalock–Taussig (BT) shunts

A
  • Partially corrects the Fallot’s abnormality by anastomosing the subclavian artery to the pulmonary artery
  • Absent radial pulse and scar
84
Q

causes of an absent radial pulse

A
  • Acute: embolism, aortic dissection, trauma, e.g. radial artery sheath
  • Chronic: atherosclerosis, coarctation, Takayasu’s arteritis (‘pulseless disease’), Blalock-Taussig (BT) Shunts
85
Q

Coarctation of Aorta

A

A congenital narrowing of the aortic arch that is usually distal to the left subclavian artery.

86
Q

Clinical signs of Coarctation of Aorta

A

• Hypertension in right ± left arm (coarctation usually occurs between left common carotid and left subclavian arteries)
• Prominent upper body pulses, absent/weak femoral pulses, radiofemoral delay
• Heaving pressure loaded apex
• Auscultation:
–> continuous murmur from the coarctation and collaterals radiating through to the back.
–> There is a loud A2.
–> There may be murmurs from associated lesions

87
Q

Associations of Coarctation of Aorta

A
  • Cardiac: VSD, bicuspid aortic valve and PDA

* Non‐cardiac: Turner’s syndrome and Berry aneurysms

88
Q

Investigation of Coarctation of Aorta

A
  • ECG: LVH and RBBB

* CXR: rib notching, double aortic knuckle (post‐stenotic dilatation)

89
Q

Management of Coarctation of Aorta

A
  • Percutaneous: endovascular aortic repair (EVAR)
  • Surgical: Dacron patch aortoplasty
  • Long‐term anti‐hypertensive therapy
  • Long‐term follow‐up/surveillance with MRA: late aneurysms and recoarctation
90
Q

Patent ductus arteriosus (PDA)

A

Continuity between the aorta and pulmonary trunk with left to right shunt
Risk factor: rubella

91
Q

Clinical signs Patent ductus arteriosus (PDA)

A
  • Collapsing pulse
  • Thrill second left inter‐space
  • Thrusting apex beat
  • Auscultation: loud continuous ‘machinery murmur’ loudest below the left clavicle in systole
92
Q

Complications of Patent ductus arteriosus (PDA)

A
  • Eisenmenger’s syndrome (5%)

* Endocarditis

93
Q

Management of Patent ductus arteriosus (PDA)

A

• Closed surgically or percutaneously

94
Q

Hypertrophic (obstructive) cardiomyopathy presentation

A

This young man has complained of palpitations whilst playing football. Examine his cardiovascular
system.

95
Q

Clinical signs of Hypertrophic (obstructive) cardiomyopathy

A

• Jerky pulse character
• Double apical impulse (palpable atrial and ventricular contraction)
• Thrill at the lower left sternal edge
• Auscultation:
–> Ejection systolic murmur (ESM) at the lower left sternal edge that radiates throughout the precordium.
–> A fourth heartsound (S4) is present due to blood hitting a hypertrophied stiff LV during atrial systole.
–> Dynamic ESM accentuated by reducing LV volume, e.g. standing from squatting or during a strain phase of Valsalva.
• There may be associated mitral valve prolapse (MVP)
• There may be features of Friedreich’s ataxia or myotonic dystrophy

96
Q

Investigation for HOCM

A

• ECG: LVH with strain (deep T‐wave inversion across precordial leads)
• CXR: often normal
• TTE: asymmetrical septal hypertrophy and systolic anterior motion of the anterior mitral
leaflet across the LVOT due to misalignment of septal papillary muscle, LVOT gradient
(rest/exercise or dobutamine stress)
• Cardiac MR: identifies apical HCM more reliably than TTE
• Cardiac catheterization: gradient accentuated by a ventricular ectopic or
pharmacological stress, identification of septals
• Genetic tests: sarcomeric proteins mutation

97
Q

Management of HOCM

A

@ Asymptomatic:
• Avoidance of strenuous exercise, dehydration and vasodilators

@ Symptomatic and LVOT gradient >30 mm Hg
••••> β‐Blockers
••••> Pacemaker
••••> Alcohol septal ablation
••••> Surgical myomectomy

@ Rhythm disturbance/high‐risk SCD
• ICD

@ Refractory:
• Cardiac transplant

@ Genetic counselling of first‐degree relatives (autosomal dominant inheritance)

98
Q

Prognosis of HOCM

A
• Annual mortality rate in adults is 2.5%
• Poor prognosis factors:
⚬⚬⚬⚬> Young age at diagnosis
⚬⚬⚬⚬> Syncope
⚬⚬⚬⚬> Family history of sudden death
⚬⚬⚬⚬> Septal thickness > 3 cm
99
Q

Jugular venous pressure waves

A

a: atrial systole
c: closure of tricuspid valve
x: movement of atrioventricular ring during ventricular systole
v: filling of the atrium
y: opening of the tricuspid valve

100
Q

scars on the Chest for Heart conditions

A
  1. Midline sternotomy (CABG, AVR, MVR)
  2. Lateral thoracotomy (MVR, mitral valvotomy, coarctation repair, BT shunt)
  3. Subclavicular (Pacemaker, AICD)
  4. Anticubital fossa (angiography)

Also look in the wrist and groins for angiography scars/bruising and legs for saphenous vein harvest used in bypass grafts.